Reverse Engineering Competitor Device Materials and Surface Coatings
Solutions
Chemical Characterization
Biocompatibility
Industries
Medical Devices; Combination Products; Drug Products

Challenge

A medical device sponsor developing a next-generation delivery system sought to better understand the materials and coatings used by a leading competitor in their connectors and housing components.

The competitor’s product demonstrated excellent clinical usability and product longevity, and the sponsor wanted to gain insights into material selection, potential surface treatments, and manufacturability strategies to inform their own design and sourcing decisions. However, publicly available documentation (IFUs, patents, regulatory summaries) lacked the specificity needed to answer key design questions.

Chemva’s Solution

Chemva designed and executed a custom reverse engineering plan targeting both bulk materials and surface coatings of the competitor’s connector and delivery components.
Our approach integrated advanced analytical testing with polymer forensics and material performance interpretation.

  1. Visual and Structural Assessment:
    • Conducted macroscopic and microscopic examination of the device components, including cross-sectional imaging and surface topography via SEM to assess material interfaces, weld lines, and any multi-material bonding regions.
    • Isolated key subassemblies such as male/female connectors, flexible tubing, and actuation interfaces for targeted analysis.
  2. Bulk Material Identification:
    • Performed Fourier-transform infrared spectroscopy (FTIR) and Raman spectroscopy to identify the polymeric backbone of each component (e.g., polycarbonate, PEEK, PETG, or proprietary blends).
    • Used Differential Scanning Calorimetry (DSC) and Thermogravimetric Analysis (TGA) to evaluate thermal properties, crystallinity, and filler content.
  3. Surface Coating Investigation:
    • Conducted contact angle measurements to detect lubricious or hydrophilic coatings and quantify surface energy changes.
    • Used FTIR to detect general coating chemistry.
  4. Strategic Insights and Reporting:
    • Identified that the competitor used a PC-ABS blend for structural connectors, likely to balance impact strength and chemical resistance.
    • Surface analysis suggested a thin hydrophilic coating, consistent with off-the-shelf or lightly modified commercial lubricious coating technologies.
    • Recommended commercial analog materials and coatings for the sponsor’s team to evaluate.

Impact Delivered

The client incorporated the findings into their design history file (DHF) and moved forward with a refined material and coating strategy grounded in real-world competitive intelligence.
Chemva’s reverse engineering analysis:

  • Enabled the sponsor to benchmark competitor material choices and identify functional design intent not obvious from public sources.
  • Provided material formulation insights that informed their own selection of materials and coatings.
  • Accelerated their development timeline by reducing trial-and-error sourcing and testing cycles.
More Case Studies
More Case Studies That Reflect Your Area of Interest
Explore additional case studies that address similar challenges, industries, or technical domains — and see how Chemva’s expertise translates across different projects.
Toxicology Risk Assessment
Establishing Toxicological/Biological Equivalence After Undisclosed Additive Change in Medical-Grade Resin
Chemva recommended a dual Toxicological Risk Assessment (TRA) strategy, using results from E&L testing
Toxicology Risk Assessment
Extractables / Leachables (E/L)
In-Silico Genotoxicity Assessment for Drug Packaging-Related Impurities
Chemva performed a tiered in-silico genotoxicity assessment using (Q)SAR tools and expert toxicological interpretation to classify the packaging-derived impurities per ICH M7 guidelines.
Toxicology Risk Assessment
Biocompatibility
Addressing Carcinogenicity Concerns Without E&L for EU MDR Submission
Chemva proposed and executed a paper-based Material Risk Assessment (MRA) specifically designed to address both genotoxic and non-genotoxic carcinogenicity pathways.
Chemical Characterization
Assessing the Impact of Antioxidant Reduction in a Container Closure System
Chemva performed a comprehensive risk assessment focused on understanding whether the antioxidant reduction would materially impact the polymer’s performance, stability, or toxicological profile.
Chemical Characterization
Biocompatibility
Resolving Unknown Extractables to Enable Pivotal Clinical Study
Chemva swiftly conducted a comprehensive Material Risk Assessment
Biocompatibility
Material Science
Defending Polymer Stability with Historical Use and Material Science
Chemva led a detailed material-specific risk assessment, supported by both scientific literature and historical clinical use.
Toxicology Risk Assessment
Avoiding Simulated E&L Testing Through Read-Across Toxicological Risk Assessment
Chemva conducted a comprehensive Toxicological Risk Assessment (TRA) using a read-across strategy, allowing us to bridge data gaps with scientifically valid surrogate information.
Chemical Characterization
Biocompatibility
Reverse Engineering Competitor Device Materials and Surface Coatings
Chemva designed and executed a custom reverse engineering plan targeting both bulk materials and surface coatings of the competitor’s connector and delivery components.
Chemical Characterization
Material Science
Biocompatibility
Establishing Material Equivalence After a Raw Material Supplier Manufacturing Site Change
Chemva conducted a comprehensive material equivalency assessment to evaluate potential variations between batches sourced from the original and new manufacturing sites.
Chemical Characterization
Toxicology Risk Assessment
Identifying Formaldehyde Risk Through Material Risk Assessment for a Medical Device
Chemva conducted a systematic, material-specific MRA, analyzing each component and processing additive and manufacturing steps to identify chemical structures or precursors associated with CoCs.
Material Science
Biocompatibility
Custom Formulating a Non-PTFE Lubricious Coating to Solve Supply Chain Constraints & Incoming Regulations
Leveraging our deep expertise in biocompatible coatings and polymer systems, Chemva led a coating reformulation and optimization program tailored to the device’s surface, application method, and clinical use.
Material Science
Material Compatibility Assessment for Solvent-Bonded Luer Hub Assembly
Chemva led a material compatibility evaluation using HansenSolubility Parameters (HSP) to scientifically assess the interaction potentialbetween each candidate hub material, the bonding solvent, and the polyurethanetubing.
Extractables / Leachables (E/L)
Biocompatibility
Toxicology Risk Assessment
Identifying Critical Gaps with E&L Protocol to Ensure Seamless PMA Application
Chemva conducted a comprehensive review of the E&L protocol, evaluating analytical strategies, extraction conditions, and toxicological relevance.
Material Science
Extractables / Leachables (E/L)
Virtual Project Management
Proactive Semi-Targeted E&L Strategy for a Polymer-Additive-Based Medical Device
Chemva’s semi-targeted E&L design eliminated potential FDA objections before they could be raised.
Material Science
Virtual Project Management
Securing Product Integrity with Reliable Raw Materials Supply
Chemva developed and implemented a risk-based supplier qualification framework
Biocompatibility
Biological Evaluation Plan (BEP) for a Next-Generation Implantable Device
Developed a risk-based BEP to meet FDA and ISO 10993-1 standards, helping the client avoid delays and save $300K through targeted testing.
Failure Analysis & CAPA
Materials
Connectors Cracking: A Root Cause Analysis and Material Selection Effort
Chemva’s systematic approach not only resolved the cracking issue but also enhanced the product’s long-term reliability and manufacturability.
Biocompatibility
Overcoming Adverse Sensitization Results
Chemva led a contextual data evaluation to assess whether the positive result represented a real clinical risk.
Biocompatibility
When Failed Cytotoxicity Is Not the Whole Story
Chemva’s strategic data interpretation helped the partner avoid unnecessary re-testing and product reformulation
Material Science
Extractables / Leachables (E/L)
Strategic Vendor Selection for Biocompatible Polymers in Inhaler Development
Chemva implemented a multi-step vendor qualification strategy to identify a reliable source of medical-grade polymer materials.
Consulting. Collaborating. Catalyzing.
Accelerating innovation through expert solutions, teamwork, and education.